SEC Form 8-K Summary
Business Context and Reporting Period
The filing is a Current Report on Form 8-K filed by Akerna Corp. on July 2, 2020, reporting events occurring at its June 26, 2020 special meeting of stockholders. The request metadata identifies American Bitcoin Corp., but the filing itself identifies Akerna Corp. as the registrant.
Akerna’s common stock and warrants traded on the Nasdaq Capital Market under the symbols KERN and KERNW, respectively. The filing does not present quarterly or annual financial results.
Key Financial Metrics and Capital Matters
- The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.
- Stockholders approved the issuance of Akerna shares in connection with the proposed Plan of Arrangement involving Ample Organics Inc., Akerna’s wholly owned Ontario subsidiary, and related parties.
- Stockholders approved the issuance of up to 800,000 common shares in connection with the option to acquire the remaining 19.6% of Solo Sciences, Inc.
- Stockholders approved an amendment to the 2019 Long Term Incentive Plan, increasing shares reserved for issuance by 525,000 to an aggregate of 1,565,038 shares.
Voting Results and Material Changes
| Proposal | For | Against | Abstentions |
|---|---|---|---|
| Nasdaq-required approval of shares issued in connection with the Arrangement | 8,562,360 | 19,576 | 30,080 |
| Approval of the Arrangement | 8,561,631 | 19,513 | 30,872 |
| Approval of up to 800,000 shares for the Solo Sciences acquisition option | 8,561,131 | 24,943 | 25,942 |
| Amendment to the 2019 Long Term Incentive Plan | 8,055,224 | 20,983 | 535,809 |
All four proposals were approved. Broker non-votes were reported as not applicable for each proposal. Compared with the prior comparable period, the filing does not provide financial or operating comparisons; the material developments are the stockholder approvals and the increase in authorized plan shares.
Outlook, Risks, Contingencies, and Unusual Items
- The approvals enabled the contemplated share issuances and Arrangement-related actions described in the company’s December 18, 2019 Arrangement Agreement and Plan of Arrangement.
- The filing does not provide management guidance, financial outlook, quantified contingencies, or discussion of specific operating risks.
- Potential dilution from the Arrangement, the Solo Sciences option, and the expanded incentive plan is a material capital-markets consideration, although the filing does not state the final number or timing of shares to be issued.
Investor Verification Checklist
- Verify the completion status, consideration, and final share issuance under the Ample Organics Arrangement.
- Verify whether and when the option to acquire Solo Sciences’ remaining 19.6% interest was exercised and how many shares were issued.
- Review the amended 2019 Long Term Incentive Plan and its effects on potential equity dilution.
- Confirm the company identity, because the supplied metadata names American Bitcoin Corp. while the filing names Akerna Corp.
- Consult the June 12, 2020 definitive proxy statement for additional transaction terms and voting details.